Description
Latin name srdlfrp
Release form
Injection.
Packing
5 ampoules of 5 ml.
Indications
Panavir is intended for the treatment of infections caused by DNA and RNA viruses:
– chronic recurrent herpetic infection
– papillomovirus infection
– viral dermatoses
– tick-borne encephalitis.
Contraindications
– individual intolerance
– patients with severe kidney disease, spleen
– childhood
– pregnancy, lactation
Panavir should not be used in patients with allergies to the components of the drug: glucose, glucose, glucose, .
Special instructions
Panavir solution for intravenous administration: when used in preparation for pregnancy, it helps to reduce the frequency of reproductive losses in case of cytomegalovirus and herpesvirus infections.
If the solution becomes cloudy, the drug is considered unsuitable for use.
Panavir gel for external and local use: it is recommended to start treatment at the earliest possible stage of the disease, at the first sign (itching, tingling, redness, feeling of tension), in this case, the development of the bladder stage of the disease can be completely prevented.
Panavir ® Gel is not intended for use in ophthalmology. When applying the gel to the face, avoid contact with eyes.
Suppositories Panavir vaginal: simultaneous treatment of sexual partners is necessary to prevent urogenital reinfection. If there is no effect, the diagnosis should be confirmed.
Influence on the ability to drive a car or perform work that requires an increased speed of physical and mental reactions. There are no data on the possibility of a negative effect of the drug on the ability to drive vehicles and carry out potentially hazardous activities that require special attention and speed of psychomotor reactions.
Composition of
1 ampoule contains panavir (purified extract of the shoots of the plant Solanum tuberosum, the main active ingredient is hexose glycoside, consisting of glucose, ramnose, arabinose, mannose, xylose, galactose, uronic acids) 0.4 mg.
Dosage and administration
Panavir in solution is used for intravenous administration of a therapeutic dose of 200 μg (contents of one ampoule or vial) of the active substance twice with an interval of 48 or 24 hours. If necessary, after a month, the course of treatment can be repeated.
Panavir solution should be injected slowly.
With herpes – 5 ml iv after 48 hours, repeat the course of treatment after 1 month or at the time of exacerbation.
For papillomovirus infection – 5 ml iv after 48 hours, then 5 ml iv once every 7 days. Only 5 injections.
With tick-borne encephalitis – 5 ml iv with an interval of 48 hours, only 3 injections.
Side effects
The drug is well tolerated, possible complications may be associated with individual intolerance and hypersensitivity to the components of the drug. In case of overdose, a reversible violation of the functions of the kidneys and spleen is possible. However, if any unwanted side effects appear, it is necessary to stop the administration of the drug and consult a doctor.
Drug Interactions
Not detected.
Overdose
Overdose has not been reported. The results of preclinical studies indicate a low toxicity of the drug.
Storage conditions
In a protected place from light, at a temperature not exceeding 25 ° C
Shelf life
2 years.
Terms and conditions
prescription
Dosage form
solution for infusion
Indications
Indications
Indications
Indications
Indications
Indications
Indications
Indications
Indications
lichen herpes, genital herpes, tick-borne encephalitis, HPV
